Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May;20(5):1067-1069.
doi: 10.1111/jth.15675.

Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fruit meets inconvenient data

Hanny Al-Samkari  1   2
Affiliations
Free article
Comment

Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fruit meets inconvenient data

Hanny Al-Samkari. J Thromb Haemost. 2022 May.
Free article
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Ogut D, Reel B, Gonen Korkmaz C, Arun MZ, Cilaker Micili S, Ergur BU. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-kappaB signaling in LPS-induced PC3 cells. Folia Histochem Cytobiol. 2016;54:171-180. doi:10.5603/FHC.a2016.0022
    1. Jordan AC, Meek JC, Kanaan A, Lensing S, Meek M. Novel pharmacological therapy for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol. 2015;26:S114.
    1. Gaillard S, Dupuis-Girod S, Boutitie F, et al. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost. 2014;12:1494-1502. doi:10.1111/jth.12654
    1. Geisthoff UW, Seyfert UT, Kubler M, Bieg B, Plinkert PK, Konig J. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study. Thromb Res. 2014;134:565-571. doi:10.1016/j.thromres.2014.06.012
    1. Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173:989-1001. doi:10.7326/M20-1443

MeSH terms

LinkOut - more resources